These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers. Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679 [TBL] [Abstract][Full Text] [Related]
7. IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays. Shah J; Liu S; Potula HH; Bhargava P; Cruz I; Force D; Bazerbashi A; Ramasamy R BMC Infect Dis; 2021 Apr; 21(1):325. PubMed ID: 33827460 [TBL] [Abstract][Full Text] [Related]
8. Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies. Cook N; Xu L; Hegazy S; Wheeler BJ; Anderson AR; Critelli N; Yost M; McElroy AK; Shurin MR; Wheeler SE Clin Biochem; 2021 Nov; 97():54-61. PubMed ID: 34453893 [TBL] [Abstract][Full Text] [Related]
9. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies. Solastie A; Virta C; Haveri A; Ekström N; Kantele A; Miettinen S; Lempainen J; Jalkanen P; Kakkola L; Dub T; Julkunen I; Melin M Microbiol Spectr; 2021 Dec; 9(3):e0113121. PubMed ID: 34787485 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer. Cameron A; Bohrhunter JL; Porterfield CA; Mangat R; Karasick MH; Pearson Z; Angeloni S; Pecora ND Microbiol Spectr; 2022 Apr; 10(2):e0250721. PubMed ID: 35389244 [TBL] [Abstract][Full Text] [Related]
11. Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community. Guarino C; Larson E; Babasyan S; Rollins A; Joshi LR; Laverack M; Parrilla L; Plocharczyk E; Diel DG; Wagner B PLoS One; 2022; 17(1):e0262868. PubMed ID: 35061843 [TBL] [Abstract][Full Text] [Related]
12. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring. Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223 [TBL] [Abstract][Full Text] [Related]
13. Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses. Pisanic N; Antar AAR; Kruczynski KL; Gregory Rivera M; Dhakal S; Spicer K; Randad PR; Pekosz A; Klein SL; Betenbaugh MJ; Detrick B; Clarke W; Thomas DL; Manabe YC; Heaney CD J Immunol Methods; 2023 Mar; 514():113440. PubMed ID: 36773929 [TBL] [Abstract][Full Text] [Related]